Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SNP-based Microdeletion and Aneuploidy RegisTry

NCT02381457 is registered in ClinicalTrials.gov with Natera, Inc. as lead sponsor.

NCT NCT02381457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02381457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SNP-based Microdeletion and Aneuploidy RegisTry
Lead sponsor
Natera, Inc.
Phase
Observational
Overall status
Completed
Start date
April 30, 2015
Completion date
June 30, 2020
Enrollment
20,960 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

1p36 deletion syndrome, 22q11 deletion syndrome, angelman syndrome, cri-du-chat syndrome, digeorge syndrome, monosomy x, prader-willi syndrome, sex chromosome abnormalities, trisomy 13, trisomy 18, trisomy 21